GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

159938 GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS

Closed 03-06 15:00:00

0.64

+0.01

+2.07%

High0.64	Low0.62	Vol41.45M
Open0.63	D1 Closing0.63	Amplitude2.71%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O26.40M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS","latestPrice":0.64,"timestamp":1772780598000,"preClose":0.627,"halted":0,"volume":41448002,"delay":0,"changeRate":0.0207,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":0.013,"latestTime":"03-06 15:00:00","open":0.626,"high":0.641,"low":0.624,"amount":26398600,"amplitude":0.0271,"askPrice":0.641,"askSize":4354,"bidPrice":0.64,"bidSize":9246,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773019800000},"marketStatusCode":5,"adr":0,"adjPreClose":0.627,"symbolType":"fund","openAndCloseTimeList":[[1772760600000,1772767800000],[1772773200000,1772780400000]],"highLimit":0.69,"lowLimit":0.564,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.099806,"marketValue":0,"turnoverRate":0,"status":0,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2026-03-09.","floatMarketCap":0},"requestUrl":"/m/hq/s/159938/wiki","defaultTab":"wiki","newsList":[{"id":"1133725281","title":"TYK MEDICINES-B Shares Surge Over 5% Following H-Share Reform Completion and New Drug Application Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1133725281","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133725281?lang=en_us&edition=fundamental","pubTime":"2026-03-06 12:01","pubTimestamp":1772769706,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) rose more than 5%, with a gain of 4.92% at the time of writing to HK$11.34, generating a turnover of HK$27.5877 million. On March 4, the company announced that the conversion...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VT","BK4588","159938","BK1161","BK4585","VXUS","BK1574","BK1515","02410","09939"],"gpt_icon":0},{"id":"1199416146","title":"DanNuo Pharma's IPO: R&D Cuts, 3-Year Loss of 376 Million Yuan, and Hidden Risks in Commercial Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=1199416146","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199416146?lang=en_us&edition=fundamental","pubTime":"2026-03-06 10:43","pubTimestamp":1772765026,"startTime":"0","endTime":"0","summary":"DanNuo Pharmaceutical (Suzhou) Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, aiming for a main board IPO. Founded in 2013, the company focuses on developing...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1515","159938","BK1161"],"gpt_icon":0},{"id":"1154241690","title":"Voices from China's Pharmaceutical Sector at the 2026 \"Two Sessions\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1154241690","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154241690?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:24","pubTimestamp":1772713461,"startTime":"0","endTime":"0","summary":"The 2026 National People's Congress (NPC) and the Chinese People's Political Consultative Conference (CPPCC), collectively known as the \"Two Sessions,\" have commenced, with the pharmaceutical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09939","159938","BK1515"],"gpt_icon":0},{"id":"1194976925","title":"Proposals from Deputies and Committee Members on Enhancing Centralized Drug Procurement and Deepening Medical Insurance Payment Reforms","url":"https://stock-news.laohu8.com/highlight/detail?id=1194976925","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194976925?lang=en_us&edition=fundamental","pubTime":"2026-03-05 16:05","pubTimestamp":1772697915,"startTime":"0","endTime":"0","summary":"During the ongoing Two Sessions, representatives have put forward suggestions to refine the volume reporting rules for centralized drug procurement. On March 5, the Fourth Session of the 14th...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","BK1161","BK1515","09939"],"gpt_icon":0},{"id":"1173857438","title":"34-Year-Old Female Leader from Chaoshan Secures Major $1.5 Billion Pharmaceutical Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1173857438","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173857438?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:31","pubTimestamp":1772627491,"startTime":"0","endTime":"0","summary":"A significant breakthrough has been achieved in the pharmaceutical business of a wealthy Thai family. On March 4, Xie Qirun, the leader of Sino Biopharmaceutical, signed an announcement finalizing an...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","BK1515","159938"],"gpt_icon":0},{"id":"1171862541","title":"Senior Pharmaceutical Analyst Leaves High-Paying Career to Pursue Buddhist Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=1171862541","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171862541?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:52","pubTimestamp":1772617928,"startTime":"0","endTime":"0","summary":"A senior pharmaceutical analyst from Guolian Minsheng Securities Company Limited has officially departed from the securities research industry. Zheng Wei, the assistant director of the research...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601456","01456","159938","BK1161","BK1574","BK1515","09939","BK1147","BK1564","161027","BK0276"],"gpt_icon":0},{"id":"1138822014","title":"TYK MEDICINES-B Completes H-Share Full Circulation Process","url":"https://stock-news.laohu8.com/highlight/detail?id=1138822014","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138822014?lang=en_us&edition=fundamental","pubTime":"2026-03-04 16:48","pubTimestamp":1772614108,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has announced that the conversion of 4.608 million non-tradable shares into H-shares was successfully completed on March 4, 2026. These newly converted H-shares are scheduled to commence trading on the Hong Kong Stock Exchange at 9:00 a.m. on March 5, 2026.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","BK1161","BK1574","02410","159938"],"gpt_icon":0},{"id":"1183838204","title":"Senior Pharmaceutical Analyst Pursues Buddhist Studies Master's Degree: What's Your Take?","url":"https://stock-news.laohu8.com/highlight/detail?id=1183838204","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183838204?lang=en_us&edition=fundamental","pubTime":"2026-03-04 16:42","pubTimestamp":1772613722,"startTime":"0","endTime":"0","summary":"A trending topic in financial circles this afternoon involves a senior pharmaceutical analyst from a securities firm—specific details are omitted to respect privacy. The analyst reportedly mentioned...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","BK1515","159938"],"gpt_icon":0},{"id":"1110333225","title":"ABBISKO-B Initiates First Patient Dosing in Phase I/II Trial for Oral KRAS G12D Inhibitor ABSK141","url":"https://stock-news.laohu8.com/highlight/detail?id=1110333225","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110333225?lang=en_us&edition=fundamental","pubTime":"2026-03-04 08:09","pubTimestamp":1772582987,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced that its subsidiary, Shanghai Abbisko Biopharmaceutical Technology Co., Ltd., has successfully administered the first dose of ABSK141, an oral, highly potent, and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","02256","BK1161","LU2488822045.USD","09939","IE00B543WZ88.USD","BK1574","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU2476274308.USD","BK1515","159938","LU2476274720.SGD"],"gpt_icon":0},{"id":"1176859477","title":"Tigermed Finalizes Divestiture of Shanghai Guanhe Medical's Entire Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=1176859477","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176859477?lang=en_us&edition=fundamental","pubTime":"2026-03-03 19:08","pubTimestamp":1772536118,"startTime":"0","endTime":"0","summary":"Tigermed (03347) has announced the completion of the sale of all issued shares of Shanghai Guanhe Medical Technology Co., Ltd. All conditions outlined in the share transfer agreement have been...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","300347","BK0077","159938","BK0216","BK1574","BK1583","LU1820825898.SGD","BK1141","BK1515","BK1576","BK0174","BK1161","03347","09939","LU1146622755.USD"],"gpt_icon":0},{"id":"1127240439","title":"FRONTAGE Subsidiary Finalizes Acquisition of Shanghai Guanhe Medical Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1127240439","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127240439?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:34","pubTimestamp":1772534060,"startTime":"0","endTime":"0","summary":"FRONTAGE (01521) has announced that its wholly-owned subsidiary, Frontage Shanghai, has completed the acquisition of Shanghai Guanhe Medical Technology Co., Ltd. for 270 million yuan. All conditions...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","09939","01521","BK1574","BK1141","BK1515","159938","BK1576"],"gpt_icon":0},{"id":"1168358662","title":"Medical Device Stocks Emerge as Top Pick for Year of the Horse, Led by Aidite's 105% Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1168358662","media":"Deep News","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168358662?lang=en_us&edition=fundamental","pubTime":"2026-03-02 14:51","pubTimestamp":1772434307,"startTime":"0","endTime":"0","summary":"Following the spotlight on innovative drugs in 2025, the focus within the pharmaceutical and biological sector for 2026 has shifted to identifying the hottest segment, a topic of keen interest for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","09939","BK1161","159938"],"gpt_icon":0},{"id":"1160117931","title":"GENFLEET-B's GFH375 Receives Breakthrough Therapy Designation in China for KRAS G12D-Mutant NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1160117931","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160117931?lang=en_us&edition=fundamental","pubTime":"2026-03-02 08:08","pubTimestamp":1772410107,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that its oral KRAS G12D (ON/OFF) inhibitor, GFH375, has been included in the Breakthrough Therapy Designation (BTD) list by the Center for Drug Evaluation (CDE) of the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","02595","BK1574","BK1161","159938"],"gpt_icon":0},{"id":"1188492549","title":"DanNuo Pharma's Commercialization Challenge: R&D Spending Declines, Nearly 800 Million Yuan Partnership Hides Performance Clauses","url":"https://stock-news.laohu8.com/highlight/detail?id=1188492549","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188492549?lang=en_us&edition=fundamental","pubTime":"2026-02-28 09:42","pubTimestamp":1772242933,"startTime":"0","endTime":"0","summary":"DanNuo Medicine (Suzhou) Co., Ltd., a biotech company focused on bacterial infections and diseases related to bacterial metabolism, submitted a listing application to the Hong Kong Stock Exchange on...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","BK1574","09939","159938"],"gpt_icon":0},{"id":"1124656732","title":"HENLIUS's Biosimilar HLX11 Receives Positive CHMP Review from EMA","url":"https://stock-news.laohu8.com/highlight/detail?id=1124656732","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124656732?lang=en_us&edition=fundamental","pubTime":"2026-02-27 22:38","pubTimestamp":1772203105,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) has announced that its drug candidate, HLX11, a biosimilar of pertuzumab, recently received a positive review opinion from the European Medicines Agency's Committee for Medicinal...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","HK0000306701.USD","HK0000165453.HKD","EMA","HK0000320264.USD","09939","BK1515","HK0000306685.HKD","BK4087","159938","HK0000320223.HKD","BK1161","CHMP","BK1574","BK4081"],"gpt_icon":0},{"id":"1193005236","title":"TYK MEDICINES-B Announces RMB 83.5 Million Capital Injection into Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=1193005236","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193005236?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:10","pubTimestamp":1772194221,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has disclosed that on February 27, 2026, after trading hours, existing shareholders, including the company, along with TYK Bio and subscribers, entered into a capital increase...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02410","BK1515","09939","BK1161","159938"],"gpt_icon":0},{"id":"1112103111","title":"Pharmaceutical Industry Update: Key Developments on February 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1112103111","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112103111?lang=en_us&edition=fundamental","pubTime":"2026-02-27 10:16","pubTimestamp":1772158565,"startTime":"0","endTime":"0","summary":"1. Jichuan Pharmaceutical Secures Exclusive Commercial Rights to Benvitimod Cream for Up to 190 Million Yuan On February 26, Jichuan Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of Hubei...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","159938","BK1161","HEXmain","09939"],"gpt_icon":0},{"id":"1136258056","title":"Yixintang to Capitalize on Market Opportunities and Expand Business Boundaries for Healthcare-Consumer Integration","url":"https://stock-news.laohu8.com/highlight/detail?id=1136258056","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136258056?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:04","pubTimestamp":1772107449,"startTime":"0","endTime":"0","summary":"On February 26, Yixintang Pharmaceutical Group Co., Ltd. responded to investor inquiries via an interactive platform, stating that Hainan’s duty-free policy can drive diversified pharmacy services...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002727","BK0077","LU1969619763.USD","LU2328871848.SGD","159938","BK0097","BK0209","BK1161","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"1114907205","title":"Zhongtai Securities: Maintaining Focus on Healthcare's Structural Opportunities and Medical AI+","url":"https://stock-news.laohu8.com/highlight/detail?id=1114907205","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114907205?lang=en_us&edition=fundamental","pubTime":"2026-02-26 07:28","pubTimestamp":1772062107,"startTime":"0","endTime":"0","summary":"Zhongtai Securities released a research report stating that the healthcare sector, which combines both technological and consumer characteristics, is expected to continue exhibiting structural trends...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600918","09939","BK1515","BK1574","BK0276","150261","BK1161","159938"],"gpt_icon":0},{"id":"1191333349","title":"Waterdrop's Yifan Pharma Deploys China's First AI-Powered Patient Matching Patent for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1191333349","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191333349?lang=en_us&edition=fundamental","pubTime":"2026-02-25 13:14","pubTimestamp":1771996477,"startTime":"0","endTime":"0","summary":"Beijing Yifan Fengshun Pharmaceutical Technology Co., Ltd., a subsidiary of Waterdrop Inc., has recently been granted a national invention patent for its independently developed \"Intelligent Patient...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4539","BK1574","159938","BK1515","09939","WDH","BK4509","BK4173"],"gpt_icon":0}],"profile":{"ret":0,"stockEarnings":[{"period":"1week","weight":-0.0244},{"period":"1month","weight":-0.0274},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.1512},{"period":"1year","weight":0.0306},{"period":"ytd","weight":-0.0139}],"compareEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":0.0054},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.2198},{"period":"ytd","weight":0.0391}],"serverTime":1772817292222,"compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS,159938,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票老虎,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票老虎国际,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS行情,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票行情,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股价,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股市,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票价格,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票交易,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票购买,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction